COVID-19 Vaccine

The American Pharmacists Association announced Monday it will withhold endorsement of the Centers for Disease Control and Prevention’s updated immunization schedule that removed COVID-19 vaccine recommendations for pregnant women and healthy children. What Happened: The CDC modified its...

The U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will no longer recommend COVID-19 vaccines for healthy children and pregnant women, sparking criticism from public health experts who cite ongoing risks. What Happened:...

Pfizer Inc. (NYSE:PFE) shares are trading lower on Wednesday after a Wall Street Journal report revealed U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine announcement. What To Know: The claim, brought forward by British pharmaceutical company GSK, alleges...

On Thursday, Novavax Inc (NASDAQ:NVAX) reported fourth-quarter 2024 sales of $88.31 million, compared to $291 million a year, beating the consensus of $84.35 million. The decrease was due to lower product sales under APA agreements. The COVID-19 vaccine maker reported an earning...

The US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by nearly 0.6% respectively. The Dow also traded down by 0.5% to 43,750.86. This came amidst news of a 0.2% rise in U.S. producer prices for October. Federal Reserve...

U.S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05, the S&P 500 held steady at 5,841.47, and the Nasdaq inched up by 0.04% to close at 18,373.61. These are the top stocks that gained the attention of retail traders and investors...

On Wednesday, Cathie Wood’s Ark Invest made significant trades involving Block Inc (NYSE:SQ) and Moderna Inc (NASDAQ:MRNA). The SQ Trade Ark Invest sold off a significant amount of shares in the Jack Dorsey-led Block, despite the Bitcoin (CRYPTO: BTC)-focused company’s recent positive...

Shares in Arbutus Biopharma (NASDAQ:ABUS) soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna Inc (NASDAQ:MRNA) in court. What Happened: Arbutus first filed its patent infringement complaint against Moderna, over the messenger-RNA...

The Centers for Disease Control and Prevention (CDC) has recommended a second annual COVID-19 vaccine for individuals aged 65 and above. This decision comes in the wake of a significant increase in COVID-19 hospitalizations among older Americans. What Happened: The CDC’s Advisory Committee...

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.  Jointly led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization (WHO...

Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc (NYSE: PFE), alleging the pharmaceutical giant misrepresented the efficacy of its widely-administered COVID-19 vaccine.  Paxton argued that Pfizer's claim of 95% effectiveness was misleading, based...

Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in individuals aged 12 and older.  Wall Street analysts are optimistic about Novavax's prospects despite its vaccine's release...

As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.  The U.S. government has shifted responsibility for vaccine distribution, administration, and payment coverage to private companies,...

Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infringement related to messenger RNA technology.  However, the financial terms of the...

European countries are actively negotiating a fresh COVID-19 vaccine procurement agreement with Moderna Inc (NASDAQ: MRNA) as concerns mount within EU health authorities regarding a surge in coronavirus infections.  Member states can express their interest in the deal individually,...